Orientin alleviates chondrocyte senescence and osteoarthritis by inhibiting PI3K/AKT pathway

Abstract

Orientin improves mitochondrial homeostasis, inhibits chondrocyte senescence, and alleviates OA progress via the PI3K/AKT/NF-κB axis, which suggests that orientin is a potential effective therapeutic agent for OA.